Sfoglia per Autore
Nanoparticles targeting pancreatic tumor.
2014-01-01 S. Mura; S. Valetti; F. Maione; B. Stella; D. Desmaële; M. Noiray; J. Vergnaud; C. Vauthier; L. Cattel; E. Giraudo; P. Couvreur
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor.
2014-01-01 S. Valetti; F. Maione; S. Mura; B. Stella; D. Desmaële; M. Noiray; J. Vergnaud; C. Vauthier; L. Cattel; E. Giraudo; P. Couvreur.
Class 3 semaphorin in angiogenesis and lymphangiogenesis
2014-01-01 Bussolino F; Giraudo E; Serini G
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy
2013-01-01 Guido Serini; Federico Bussolino; Federica Maione; Enrico Giraudo
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer
2013-01-01 Capano S; Maione F; Meda C; Monini P; Ensoli B; Sgadari C; Bussolino F and Giraudo E
Targeted nanoparticles for pancreatic cancer.
2013-01-01 S. Valetti; B. Stella; S. Mura; F. Maione; D. Desmaële; C. Vauthier; M. Noiray; E. Giraudo; L. Cattel; P. Couvreur
The role of semaphorins and their receptors in vascular development and cancer
2013-01-01 Chenghua Gu; Enrico Giraudo
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects.
2013-01-01 S. Valetti; B. Stella; S. Mura; D. Desmaële; F. Maione; E. Giraudo; L. Cattel; P. Couvreur
Targeted nanoparticles for pancreatic cancer.
2013-01-01 S. Valetti; B. Stella; S. Mura; F. Maione; D. Desmaële; C. Vauthier; M. Noiray; E. Giraudo; L. Cattel; P. Couvreur
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers
2013-01-01 Zanivan S; Maione F; Hein MY; Hernández-Fernaud JR; Ostasiewicz P; Giraudo E; Mann M
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
2012-01-01 Maione F; Capano S; Regano D; Zentilin L; Giacca M; Casanovas O; Bussolino F; Serini G; Giraudo E
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth
2012-01-01 Carrer A; Moimas S; Zacchigna S; Pattarini L; Zentilin L; Ruozi G; Mano M; Sinigaglia M; Maione F; Serini G; Giraudo E; Bussolino F; Giacca M
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
2012-01-01 Casazza A;Kigel B;Maione F;Capparuccia L;Kessler O;Giraudo E;Mazzone M;Neufeld G;Tamagnone L
Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer
2012-01-01 S. Capano; F. Bussolino; E. Giraudo
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects.
2012-01-01 S. Valetti; B. Stella; S. Mura; D. Desmaële; F. Maione; E. Giraudo; L. Cattel; P. Couvreur
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects
2012-01-01 S. Valetti; B. Stella; D. Desmaële; S. Mura; F. Maione; E. Giraudo; L. Cattel; P. Couvreur
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism.
2012-01-01 Napione L; Strasly M; Meda C; Mitola S; Alvaro M; Doronzo G; Marchiò S; Giraudo E; Primo L; Arese M; Bussolino F.
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects
2012-01-01 S. Valetti; B. Stella; D. Desmaële; S. Mura; F. Maione; E. Giraudo; L. Cattel; P. Couvreur
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages
2012-01-01 Meda C; Molla F; De Pizzol M; Regano D; Maione F; Capano S; Locati M; Mantovani A; Latini R; Bussolino F; Giraudo E
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia.
2011-01-01 Maione F; Capano S; Regano D; Zentilin L; Giacca M; Bussolino F; Serini G; Giraudo E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Nanoparticles targeting pancreatic tumor. | 2014 | S. Mura; S. Valetti; F. Maione; B. Stella; D. Desmaële; M. Noiray; J. Vergnaud; C. Vauthier; L. Cattel; E. Giraudo; P. Couvreur | |
| Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. | 2014 | S. Valetti; F. Maione; S. Mura; B. Stella; D. Desmaële; M. Noiray; J. Vergnaud; C. Vauthier; L. Cattel; E. Giraudo; P. Couvreur. | |
| Class 3 semaphorin in angiogenesis and lymphangiogenesis | 2014 | Bussolino F; Giraudo E; Serini G | |
| Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy | 2013 | Guido Serini; Federico Bussolino; Federica Maione; Enrico Giraudo | |
| HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer | 2013 | Capano S; Maione F; Meda C; Monini P; Ensoli B; Sgadari C; Bussolino F and Giraudo E | |
| Targeted nanoparticles for pancreatic cancer. | 2013 | S. Valetti; B. Stella; S. Mura; F. Maione; D. Desmaële; C. Vauthier; M. Noiray; E. Giraudo; L. Cattel; P. Couvreur | |
| The role of semaphorins and their receptors in vascular development and cancer | 2013 | Chenghua Gu; Enrico Giraudo | |
| Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. | 2013 | S. Valetti; B. Stella; S. Mura; D. Desmaële; F. Maione; E. Giraudo; L. Cattel; P. Couvreur | |
| Targeted nanoparticles for pancreatic cancer. | 2013 | S. Valetti; B. Stella; S. Mura; F. Maione; D. Desmaële; C. Vauthier; M. Noiray; E. Giraudo; L. Cattel; P. Couvreur | |
| SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers | 2013 | Zanivan S; Maione F; Hein MY; Hernández-Fernaud JR; Ostasiewicz P; Giraudo E; Mann M | |
| Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice | 2012 | Maione F; Capano S; Regano D; Zentilin L; Giacca M; Casanovas O; Bussolino F; Serini G; Giraudo E | |
| Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth | 2012 | Carrer A; Moimas S; Zacchigna S; Pattarini L; Zentilin L; Ruozi G; Mano M; Sinigaglia M; Maione F; Serini G; Giraudo E; Bussolino F; Giacca M | |
| Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. | 2012 | Casazza A;Kigel B;Maione F;Capparuccia L;Kessler O;Giraudo E;Mazzone M;Neufeld G;Tamagnone L | |
| Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer | 2012 | S. Capano; F. Bussolino; E. Giraudo | |
| Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. | 2012 | S. Valetti; B. Stella; S. Mura; D. Desmaële; F. Maione; E. Giraudo; L. Cattel; P. Couvreur | |
| Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects | 2012 | S. Valetti; B. Stella; D. Desmaële; S. Mura; F. Maione; E. Giraudo; L. Cattel; P. Couvreur | |
| IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. | 2012 | Napione L; Strasly M; Meda C; Mitola S; Alvaro M; Doronzo G; Marchiò S; Giraudo E; Primo L; Arese M; Bussolino F. | |
| Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects | 2012 | S. Valetti; B. Stella; D. Desmaële; S. Mura; F. Maione; E. Giraudo; L. Cattel; P. Couvreur | |
| Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages | 2012 | Meda C; Molla F; De Pizzol M; Regano D; Maione F; Capano S; Locati M; Mantovani A; Latini R; Bussolino F; Giraudo E | |
| Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. | 2011 | Maione F; Capano S; Regano D; Zentilin L; Giacca M; Bussolino F; Serini G; Giraudo E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile